NEWARK, DE / ACCESSWIRE / March 30, 2023 / The global malignant pleural effusion market is anticipated to create lucrative growth opportunities over the forecast period by registering a CAGR of 6% from 2023 to 2033. The global market is expected to garner a market value of US$ 4.5 Billion in 2023 and is expected to accumulate a market value of US$ 8.06 Billion by 2033.
According to the Future Market Insights historical analysis, the global malignant pleural effusion market registered a CAGR of 4% from 2018 to 2022. The growth of the market in the current evaluation period is expected to fuel due to the increasing incidence of pleural effusion disease and rising awareness of advancement in pleural effusion treatment with different types of techniques.
Clinical examinations and procedures are rapidly carried out to diagnose the condition, which helps various medical professions in making additional and efficient decisions about medicine, testing, and recuperations. Such aforementioned factors are likely to accelerate market expansion throughout the projection period. Recent epidemiological data from WHO suggest that approximately more than one million pleural effusions are diagnosed in the United States each year.
For Details on Vendors and Their Offerings - Request A Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16230
Numerous factors such as awareness and health, diagnostics, and pathology segments are improving in developing countries nowadays which grows the therapeutics market. The research and development activities in the field like emerging novel therapeutics, increasing the efficacy of medicine as well as treatment. In addition to that, selling campaigns initiated by global players are growing the market progressively. Increasing focus by government organizations and private agencies like WHO and pharmaceutical companies to create awareness of pleural effusions is fuelling market growth.
Report Highlights
The surging prevalence of malignant pleural effusion disease is one of the greatest drivers of the global malignant pleural effusion market. Various types of research were conducted over recent years, in order to find a correlation between the virus infection and pleural effusion.
The expensive treatment of Malignant Pleural Effusion, less awareness of Malignant Pleural Effusion disease, and insubstantial treatment options are hampering the market growth.
Recent Developments
The article "Prevalence and Clinical Outcomes of Pleural Effusion in Covid-19 Patients: A Systematic Review and Meta-Analysis" published in January 2022 showed that pleural effusion is related to the risk and prognosis of Covid-19 disease.
Pleural effusion is likely to be utilized as a prognostic indicator in order to assess the likelihood of poorer outcomes within sick patients. As a result, the researchers of the above-mentioned research article advised that hospitalized Covid-19 patients with pleural effusion be handled promptly. Considering these in-depth studies, the pandemic showed a considerable impact on the market studied.
Ask More About This Market's Geographical Distribution Along With a Detailed Analysis of the Top Regions@ https://www.futuremarketinsights.com/ask-question/rep-gb-16230
Competitive Landscape
Key players operating in the global malignant pleural effusion market comprise of Allakos, iCo Therapeutics, Akari Therapeutics, and Santen.
In September 2021, BDR Pharma launched BIAPENEM to treat patients with intra-abdominal infections, lower respiratory infections, or complicated urinary tract infections. Biapenem is widely distributed and penetrates well into various tissues (e.g. lung tissue) and body fluids (e.g. sputum, pleural effusion, abdominal cavity fluid).
In April 2022, the study titled "IFN-γ Combined with T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites" was registered in ClinicalTrials.gov for Malignant Pleural Effusion.
More Insights into the Malignant Pleural Effusion Market
The Asia Pacific region is anticipated to dominate the global malignant pleural effusion market over the assessment period. The region is expected to grow with a CAGR of 5%. The growth of the market is likely to surge owing to the increasing awareness, significant increases in healthcare spending, and a rising frequency of malignant pleural effusion in the region.
Asia Pacific is a dominant market due to the increase in point care approach to health & care. An increasing number of hospitals in India and China makes a promising market for the Pleural effusions treatment market worldwide.
The North American region is likely to acquire a market share of about 45% during the assessment period. The growth is attributed to the rising prevalence of pleural effusions in the region. An article published by WebMD LLC in October 2021 stated that approximately 1.5 million pleural effusions are diagnosed in the United States every year and in industrialized countries, the estimated prevalence of pleural effusion is 320 cases per 100,000 people.
Key Segments Profiled in the Malignant Pleural Effusion Industry Survey
By Diagnosis:
- Imaging Tests
- Pleural Thoracentesis
- Pleural Fluid Cytology
- Immunohistochemical Tests
- Pleural Biopsy
- Thoracoscopy/Pleuroscopy
By End User:
- Hospitals
- Ambulatory Clinics
- Others
By Treatment:
- Systemic Therapy
- Therapeutic Thoracentesis
- Thoracic Drainage and Pleurodesis
- Indwelling Pleural Catheter
Browse Detailed Summary of Research Report@ https://www.futuremarketinsights.com/reports/malignant-pleural-effusion-market
Table of Content
1. Executive Summary | Malignant Pleural Effusion Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
Buy Now to Gain Access to Detailed Information About Each Segment and Identify Key Trends, Drivers, and Challenges in the Market@ https://www.futuremarketinsights.com/checkout/16230
Have a Look at Related Reports of Healthcare domain
Stem Cell Therapies Market Size: The stem cell therapy market is expected to grow at a CAGR of 16.7% to USD 401 million by 2026, up from USD 187 million in 2021.
Systemic Lupus Erythematous SLE Drugs Market Share: The systemic lupus erythematosus (SLE) drugs market is projected to record a CAGR of 5% during the forecast period, up from US$ 183.3 Billion in 2020, to reach a valuation of US$ 329.18 Billion by 2032.
Surgical Navigation System Market Demand: The surgical navigation system market is projected to attain a CAGR of 6.2% during the forecast period, up from US$ 940 Mn in 2020 to reach a valuation of US$ 1,700 Mn by 2030.
Predictive Analytics Market Trends: With 15.8% CAGR during 2022 - 2032, the Predictive Analytics market is likely to reach a valuation of US$ 55.5 Billion by 2032.
Hernia Mesh Devices Market Forecast: With a projected CAGR of 3.4% for the next ten years, the Hernia Mesh Devices market is likely to reach a valuation of nearly US$ 6.5 Billion during 2022 - 2032.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the UK, US, and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
LinkedIn| Twitter| Blogs | YouTube
For Sales Enquiries: [email protected]
SOURCE: Future Market Insights, Inc.